A Randomised Controlle Study of Vaginal Bromocriptine and Oral Carbegoline in treating Hyperprolacrinemia among women Attending Infertility Clinic in Abuth
- Conditions
- Fertility-female
- Registration Number
- PACTR202105785593643
- Lead Sponsor
- Irshad Asma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
1.Infertile women with hyperprolactinemia confirmed by measuring fasting serum prolactin levels.
2.Women who give informed consent to participate in the study.
3.Women who are motivated to comply with study requirements including clinic visits, repeated blood sampling, vaginal drug administration and timely use of medication.
1.Women with space occupying lesions or other complications requiring urgent intervention.
2.Women with active genital tract infections or cancers.
3.Renal or hepatic insufficiency.
4.Women who were already on treatment at the time of the study.
5.Women who were unable to provide informed consent.
6.Women with allergies to any component of the drugs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.